Results 131 to 140 of about 6,787 (165)

[Chinese expert consensus on the use of standardized second-line drugs for primary hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Translational Medicine Branch, China Association of Gerontology and Geriatrics, Society of Hepatology, Beijing Medical Association, Expert Committee on Liver Cancer, Chinese Society of Clinical Oncology.   +5 more
europepmc   +1 more source

["Chongqing experiences" in treatment of bone infections]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Xie Z.
europepmc   +1 more source

[Guideline for the diagnosis and treatment of chronic myeloid leukemia in China (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Chinese Society of Hematology, Chinese Medical Association.   +1 more
europepmc   +1 more source

[Tumor-secreted dentin sialophosphoprotein induces oxaliplatin resistance in colorectal cancer through an integrin αvβ3-dependent pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liu C, Ning Z, Wu J, Liu W, Lin C, Xu J, Zhou R, Zhao L.   +7 more
europepmc   +1 more source

2021至2023年不动杆菌属细菌的临床分布和耐药性分析 附视频

Zhongguo shiyan zhenduanxue
不动杆菌属是革兰阴性杆菌，多为球杆形，不发酵糖类，对营养要求一般，可广泛存在于自然界和医院环境中[1-2]。痰液、尿液、血液、脓汁等标本中均可分离培养出不动杆菌属，是仅次于假单胞菌属的引起院内感染的重要致病菌[3-4]。近年来，不动杆菌属的分离率呈不断上升趋势，该菌属除了本身固有耐药机制，还可产生获得性耐药机制，因此容易对多种抗菌药物产生耐药性，临床用药的选择严重受限[5-7]。
doaj   +2 more sources

[Research progress on toxic shock syndrome due to group A <i>Streptococcus</i> infection in children]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wang HY, Zhou W, Huang LS.
europepmc   +1 more source

[Research progress on protein lactylation modification in malignant tumors]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Dong H, Chen H, Zhang C.
europepmc   +1 more source

[Research Progress of Peripheral Immune Tolerance in Oral Diseases]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Wen K, Zhang P, Peng X.
europepmc   +1 more source

[Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors]. [PDF]

Zhongguo Fei Ai Za Zhi
Feng Y, Sun Y, Hao X, Yang H, Lu A, Liu Y, Xia J, Feng L, Jiang M, Zhao X.   +9 more
europepmc   +1 more source

[Conversion therapy for hepatoid adenocarcinoma of the stomach: A case report]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Li J, Chen L, Tang J, Wu Y, Wang A.
europepmc   +1 more source